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Abstract
Background Children with congenital nephrotic syndrome (CNS) commonly develop end stage renal failure in infancy and
require dialysis, but little is known about the complications and outcomes of dialysis in these children.
Methods We conducted a retrospective case note review across members of the European Society for Pediatric Nephrology
Dialysis Working Group to evaluate dialysis management, complications of dialysis, and outcomes in children with CNS.
Results Eighty children (50%male) with CNS were identified form 17 centers over a 6-year period. Chronic dialysis was started
in 44 (55%) children at a median age of 8 (interquartile range 4–14) months. Of these, 17 (39%) were on dialysis by the age of
6 months, 30 (68%) by 1 year, and 40 (91%) by 2 years. Peritoneal dialysis (PD) was the modality of choice in 93%, but 34%
switched to hemodialysis (HD), largely due to catheter malfunction (n = 5) or peritonitis (n = 4). The peritonitis rate was 0.77 per
patient-year. Weight and height SDS remained static after 6 months on dialysis. In the overall cohort, at final follow-up, 29
children were transplanted, 18 were still on dialysis (15 PD, 3 HD), 19 were in pre-dialysis chronic kidney disease (CKD), and
there were 14 deaths (8 on dialysis). Median time on chronic dialysis until transplantation was 9 (6–18) months, and the median
age at transplantation was 22 (14–28) months.
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Conclusions Infants with CNS on dialysis have a comparable mortality, peritonitis rate, growth, and time to transplantation as
infants with other primary renal diseases reported in international registry data.
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Introduction
Despite advances in pediatric dialysis therapy, dialysis in in-
fants remains challenging with increased mortality, higher rate
of infections, and poor growth compared to older children and
adults [1, 2]. Children with congenital nephrotic syndrome
(CNS) account for approximately 15% of infants who start
dialysis at less than 1 year of age [3, 4]. They usually start
dialysis in early infancy and may also be prone to complica-
tions secondary to hypoalbuminemia and low immunoglobu-
lin levels, such as infections, thrombosis, impaired nutritional
status, and growth [5, 6]. In a review across the European
Society for Paediatric Nephrology (ESPN) dialysis working
group, we have shown that in children with NPHS1 muta-
tions, there is no clear genotype-phenotype correlation and
the severity of the clinical presentationmay vary.We therefore
suggest that an individualized, stepwise approach with
prolonged conservative management may be a reasonable al-
ternative to early bilateral nephrectomies and dialysis in chil-
dren with CNS due to NPHS1 mutations [7].
Due to the rarity of CNS, details of dialysis in infants with
CNS are scarce and no recommendations are available [5, 8].
Recently, data on renal and patient survival in children with
CNS were published by the French group [9] and data on
dialysis and transplantation outcomes by the European Renal
Association/European Dialysis and Transplantation
Association (ERA/EDTA) registry [4]. However, specific in-
formation on the dialysis management and complications are
not available from those studies.
We performed a retrospective case note review across all
members of the ESPN dialysis working group in order to
evaluate the current practice of dialysis management and the
morbidity and outcomes of dialysis in children with CNS
across Europe. Outcomes in the CNS patients were compared
with international registry studies reporting on infants with
other primary diseases who required dialysis.
Patients and methods
A retrospective case note review on the dialysis management
of children with CNS was performed across all members of
the ESPN Dialysis working group which includes 22 centers
from 15 European countries. Together, these centers manage
over 250 pediatric peritoneal dialysis (PD) and hemodialysis
(HD) patients per year and perform about 180 renal
transplants per year. Infants with a diagnosis of CNS between
01/01/2010 and 31/12/2015 were included. Infants with ne-
phrotic syndrome of any other type, presentation after the first
3 months of life, or those where complete data could not be
obtained were excluded.
Eighty-eight children with CNS were identified in the 6-
year study period. Eight children had to be excluded as the
diagnosis of CNS was unclear (n = 4), data was incomplete
(n = 3), or consent was withdrawn (n = 1). The final dataset
consisted of 80 children from 17 centers: 25 from Helsinki
(Finland); 10 from London (UK); 8 each from Heidelberg
(Germany) and Barcelona (Spain); 4 each from Padova
(Italy) and Ankara (Turkey); 3 each from Bologna (Italy),
Athens (Greece), Istanbul Marmara (Turkey), and Lyon
(France); 2 each from Milan (Italy) and Malta (Malta); and 1
each from Genova (Italy), Istanbul Cerrahpasa (Turkey),
Erciyes (Turkey), Adana (Turkey), and Gazi (Turkey).
The following information was collected: demographics
and presenting features, dialysis specific data: need for short
(< 3 months) or chronic (≥ 3 months) dialysis, parameters at
start of dialysis (age, weight, S-albumin, S-creatinine), dialy-
sis modality at start, dialysis prescription, dialysis modality
changes, complications (peritonitis, sepsis, line infections,
thrombosis), growth on dialysis, and outcome. Molecular
screening was performed in the local center according to the
center-specific standards. Details on the genetic background
of each patient are provided in Dufek et al. [7].
Data were pseudonymised and entered into an electronic
database that was analyzed in a central unit (Great Ormond
Street Hospital) and verified by email correspondence and at
meetings of the group.
Statistical analysis
Most of the analyses are of a descriptive nature. Continuous
variables are presented as median with interquartile range
(IQR). Categorical variables are presented as number and per-
centage. For group comparison of continuous variables, the
non-parametric Mann-Whitney U test was used, and for com-
parison of inter-individual changes, the Wilcoxon signed rank
test. For group comparison of categorical variables, the
Pearson Chi-square test or Fisher’s exact t test was used.
Kaplan-Meier curves were used to determine the renal surviv-
al time with start of dialysis or transplantation as endpoints.
Censored were patients who died or reached end of follow-up.
Statistics were calculated using SPSS Statistics 24.0 for Mac
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(IBM Corporation). A p value of < 0.05 was considered
significant.
Results
Demographic details
In total, 80 children (50% male, 90% Caucasian) with CNS
were included. Demographic details and details at presenta-
tion are described in a previous study [7]. Briefly, children
presented at a median age of 9 (2–45) days with a median S-
albumin of 11 (8–16) g/L and S-creatinine of 27 (16–56, max
480) μmol/L. A genetic diagnosis was confirmed in 69 (86%)
(NPHS1 in 55 (69%), WT1 in 9 (11%), NPHS2 in 1 (1.3%),
LAMB2 in 2 (2.5%), PLCE1 in 1 (1.3%) and in 1 (1.3%) a
mutation in a new gene, SGPL-1, was found [10]). No muta-
tion was found in 11 (14%) children [7].
Details of dialysis therapy
Fifty-five (69%) children received dialysis (both acute or
chronic dialysis) during the study period at a median age of
8 (4–15) months. The infants who required dialysis first pre-
sented at an age of 6 (2–32) days with a median S-albumin of
11 (7–16) g/L and S-creatinine of 29 (17–84) μmol/L. When
analyzed in sub-groups based on their underlying genetic di-
agnoses, dialysis was performed in 34 of 55 (62%) children
with NPHS1, 1 (100%) child with NPHS2, all 9 (100%) chil-
dren with WT1, and 11 of 15 (73%) children with other diag-
noses. In the whole cohort, the median renal survival time
(defined as the time from birth until dialysis or pre-emptive
transplantation, whichever came first) was 13 (95% CI: 8.6–
17.4) months (Fig. 1a). The median renal survival time was 15
(95% CI: 8.6–21.4) months for NPHS1, 30 months for
NPHS2, 2 (95% CI: 0.6–3.4) months for WT1, and 10 (95%
CI: 0.3–19.7) months for the others (Fig. 1b).
For further assessment, dialysis therapy was divided into
short-term dialysis (< 3 months) and chronic dialysis (≥
3 months), with the focus on chronic dialysis.
Short-term dialysis
Eleven children (14%) received short-term dialysis. Three re-
ceived acute renal replacement therapysecondary to acute flu-
id overload (n = 2) and acute kidney injury secondary to sepsis
(n = 1). Of these three, one (age 40 months) recovered renal
function (estimated glomerular filtration rate 25 ml/min/
1.73 m2) and 2 children died, 1 on PD secondary to severe
prematurity (gestational age 27 weeks) and in the other with-
drawal of care was decided while on dialysis. A further eight
children received dialysis for < 3 months: four proceeded to
transplantation, three were still within 3 months of dialysis by
the termination of the study, and one died after 1 month on
HD.
Chronic dialysis
Chronic dialysis (defined as dialysis for ≥ 3 months) was per-
formed in 44 (55%) children, of whom 25 had a diagnosis of
NPHS1 mutation, 1 had a NPHS2 mutation, 7 had a WT1
mutation, and 11 had other diagnosis. Median age at the start
of chronic dialysis was 8 (4–14) months, median weight 8.25
(5.8–9.25) kg, median serum creatinine 242 (175–291)
a
b
Fig. 1 a Kaplan-Meier curve for overall renal survival from birth until
start of dialysis or transplantation. Total n = 80. bKaplan-Meier curve for
renal survival according to underlying diagnosis from birth until start of
dialysis or transplantation. NPHS1 n = 55, NPHS1 n = 1, WT1 n = 9,
others n = 15
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μmol/l, andmedian serum albumin 21 (17–28) g/L. Seventeen
(39%) children required dialysis by the age of 6 months, 30
(68%) by 1 year, and 40 (91%) by 2 years. Twelve (29%) had
residual urinary output.
Of these, 23 (52%) children had nephrectomies before
commencing dialysis (18 bilateral nephrectomies, 2 unilateral
nephrectomy with second kidney removed after start of dial-
ysis, and 3 unilateral nephrectomy only), and 8 (18%) children
had bilateral nephrectomies after commencing dialysis, while
13 (30%) did not have nephrectomies during the study period.
Bilateral nephrectomies were performed in 19 (76%) children
with NPHS1, in no child with NPHS2, in 6 (86%) children
withWT1 (as 1 child died before second nephrectomy), and in
3 (27%) children with other diagnosis at a median age of 8 (6–
14) months. The median S-creatinine just prior to performing
bilateral nephrectomies was 19 (13–246) μmol/l.
Choice of chronic dialysis in children with CNS
Forty-one children (93%) initiated dialysis on PD. Continuous
cycling PD (CCPD) with a day exchange or CCPD with a dry
day were the commonest prescriptions with 13 (32%) each,
followed by CCPD with a last bag fill in 8 (20%), continuous
ambulatory PD in 6 (15%), and tidal PD in one (2%). Details
of the PD prescriptions of patients on CCPD are given in
Supplementary Table 1. Three (7%) children commenced di-
alysis on HD (one with hepatic fibrosis and extensive ascites,
one due to social reasons, and one due to lack of chronic PD
program in the dialysis center).
Fourteen (34%) children needed to switch to HD (4 tran-
siently and 10 permanently). Reasons for switching to HD
were PD catheter dysfunction or inadequate ultrafiltration
(n = 5), peritonitis (n = 4), development of pleural effusion
(n = 2), abdominal surgery (n = 2), and family preference
(n = 1). No patient who initially commenced on HD switched
to PD. Children who were started on PD were younger com-
pared to those who were started on HD (7 vs 17 months, p =
0.05).
Infectious complications of chronic dialysis
Of the 41 children on chronic PD, 20 (49%) developed peri-
tonitis during the study period, with a total of 40 peritonitis
episodes in 675 patient months on PD, giving a peritonitis rate
of 0.77 per year at risk. Ten (50%) patients who developed
peritonitis started PD at an age less than 6 months and 16 of 20
(80%) at an age less than 1 year. There was no difference in
children who underwent nephrectomies compared to those
without nephrectomies (48% versus 50%, p = 0.92). The
commonest organismwas Staphylococcus epidermidis (33%).
During the study period, 17 children received HD at some
point during the study; all were via a central venous line
(CVL). Only one patient developed a CVL infection, but none
had septic episodes.
Non-infectious complications of chronic dialysis
None of the children on PD developed thrombosis while on
dialysis. One child on HD developed a CVL-related thrombo-
sis in the right jugular vein that was treated with therapeutic
anticoagulation with heparin. Ten (24%) children developed
hernias after starting PD, with no difference in children who
underwent nephrectomies compared to those without nephrec-
tomies (28% versus 17%, p = 0.46): 7 were inguinal hernias
(bilateral in 2 children), 1 was an abdominal wall hernia, and
in 2 cases, the site of hernia was not specified. Three children
(7%) had pleural effusions of which 2 were switched to HD.
Growth on chronic dialysis
Anthropometric data were collected every 6months from birth
(Fig. 2a, b). Using the dry weight based on clinical assess-
ment, the median weight SDS at the start of dialysis was − 1
(− 2.22 to + 0.32) and showed a non-significant decrease to −
1.65 (− 2.80 to − 0.27) SDS after 6 months on dialysis (p =
0.37; intra-individual change − 0.78 (− 1.45 to + 1.40)). The
median height SDS at the start of dialysis was − 1.13 (− 2.48
to − 0.21) and showed a non-significant change to − 1.33 (−
2.70 to − 0.19) after 6 months on dialysis (p = 0.56; intra-
individual change + 0.05 (− 0.78 to + 0.41)) (Fig. 2c).
Final outcomes
At final follow-up, the median age of the overall cohort was
31 (14–49) months. Twenty-nine (36%) children were
transplanted, 18 (23%) children were still on dialysis (15
PD, 3 HD), 19 (24%) were in pre-dialysis CKD, and there
were 14 (18%) deaths.
Twenty-nine of 80 (36%) children received a transplant
during the study period—24 of 44 (55%) children on chronic
dialysis, 4 children after a short dialysis period of less than
3 months, and one child in pre-dialysis CKD. Fifteen trans-
plants were living related. The median age at transplantation
was 22 (14–28) months and the median time on chronic dial-
ysis before transplantation was 9 (6–18) months.
Fourteen children (18%) died during the study period.
Three children died within 3 months of dialysis onset, 5 on
chronic dialysis. The latter (4 PD, 1 HD) died at a median age
of 11 (5–51) months after a median dialysis time of 4 (3–31)
months (Fig. 3). Causes of death in patients on dialysis were
sepsis in 3 (1 HD, 2 PD), cardiac arrest in 2 (1 PD, 1 HD),
severe prematurity in 1 (PD), and withdrawal of active treat-
ment in 2 (1 PD, 1 CVVH).
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Discussion
We describe a large multi-center series on children with CNS
with a focus on the complications, growth, and outcomes on
dialysis. Due to the rarity of CNS, the literature is generally
scarce. Most studies, including transplant outcomes in a large
North American registry report (NAPRTCS) of 132 CNS pa-
tients [11], were performed over two decades ago [12, 13]. A
recent ERA/EDTA study reported on 170 children with CNS,
comparing outcomes of dialysis and graft survival between
children with NPHS1 and those with renal dysplasia, found
a comparable 5-year patient survival on dialysis [4]. However,
this registry focused on children with NPHS1 only and did not
report on complications of dialysis. The French study with 55
CNS patients focuses on general management of CNS and
gives insight in the overall patient and renal survival of chil-
dren with CNS but details on dialysis and its complications are
not elaborated [9].
We report a cohort of 80 children with CNS, of which 86%
had a confirmed underlying genetic diagnosis. This is similar
to findings of the recent French study, where in 84% of the
children, a causative mutation was identified [9]. In our cohort
of 80 children with CNS, chronic dialysis was required in
55%, with nearly all children starting dialysis in the first
2 years of life. PD was clearly the modality of choice and
was commenced in 93%. The percentage of CNS patients
starting on PD is slightly higher compared to infants on dial-
ysis with other primary renal diseases (PRD), where 57–86%
are started on PD as first choice [4, 14–16]. HD as an alterna-
tive to PD in infants has been supported by recent studies,
showing no difference in patient survival between the two
modalities [14–16]. Although numbers are small, we did not
find any difference in complication rate, growth, transplanta-
tion rate, or survival in CNS infants started on PD or HD,
suggesting that although HD is not the modality of first
choice, it is acceptable in infants with CNS. Importantly,
one-third of infants in our study needed to switch modalities
before eventual transplantation, mainly due to peritonitis or
PD catheter-related problems. An ESPN/ERA-EDTA registry
study [14] and the NAPRTCS registry [17] on infant dialysis
due to other PRDs report similar frequencies and causes of
modality change; 25% and 14%, respectively, with peritonitis
and excessive infections being the main reasons for modality
change from PD to HD [14, 17].
Infants with CNS on PD might be at higher risk of perito-
nitis, particularly in the first months of treatment, due to the
low immunoglobulin levels and in some cases due to the im-
paired nutritional status, depending on the proteinuria levels.
In our study, the peritonitis rate was 0.77 per patient year at
risk which is above the current ISPD recommendation of 0.5
per patient year at risk [18]. However, compared to peritonitis
rates reported in infants with different PRDs in developed
countries, which vary from 0.58 episodes per patient-year in
the Italian registry study [3], over 0.68 reported by NAPRTCS
[19], 1.1 episodes per patient-year in a UK cohort [20],
a b c 
Fig. 2 a Weight SDS in 6 monthly steps until 2 years of age, then 12
monthly until 5 years of age. b Height SDS in 6 monthly steps until
2 years of age, then 12 monthly until 5 years of age. c Weight SDS and
height SDS at the start of chronic dialysis and 6 months after. P values for
Wilcoxon signed rank test displayed
Fig. 3 Kaplan-Meier curve for patient survival on chronic (> 3 months)
dialysis. Total n = 44
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and 1.7 episodes per patient-year in US cohorts [21], children
in our study seem to have a comparable peritonitis rate com-
pared to children with other PRDs on PD. Half of the children
who developed peritonitis in our study started on dialysis at an
age less than 6 months. This increased risk for peritonitis in
younger children on PD has also been reported by NAPRTCS,
where children less than 1 year had an annualized peritonitis
rate of 0.79 per patient-year compared to an annualized rate of
0.67 per patient-year in children older than 1 year, and 0.57
per patient-year in those above 12 years of age [22].
Children with CNS on dialysis may be at higher risk of
thrombosis secondary to hypoalbuminemia. However, reports
on this complication are rare and expert opinions on use of
antithrombotic treatment vary [23]. In our population, only
one child (2%) developed a thrombus while on hemodialysis,
which is even less than reported in some studies where 38% of
children younger than 2 years on HD had central vein throm-
bosis [24].
The risk of poor growth might be higher in infants with
CNS on dialysis due to the above mentioned factors. In our
series, growth, expressed by both weight and height SDS, of
children with CNS on dialysis remains unsatisfactory, but
comparable to those reported in other studies of infants on
dialysis with different PRDs. The recent ERA/EDTA registry
showed catch up growth in non-Finnish NPHS1 patients on
dialysis, but static growth in CAKUT patients on dialysis [4].
In our population, the weight SDS tends to decrease further
while on dialysis and the height SDS tend to remain static. The
decrease in weight SDS may, at least in part, reflect the de-
crease in edema after starting dialysis, whereas the static
height SDS is comparable to previous reports of stable growth
in children with different PRDs after starting on dialysis [1,
20, 25].
The overall transplantation rate for children on chronic di-
alysis was 55% after a median time of 9 months on chronic
dialysis, which is comparable to that of the Italian registry [3]
(transplantation rate of 39% after a median time on dialysis of
29 months) and that of the ESPN/ERA-EDTA registry study
on infant dialysis [14] (cumulative 5-year transplantation rate
of 70%). In general, the overall patient and graft survival post-
transplantation of children with CNS are comparable to
CAKUT patients as investigated in detail by the ERA/EDTA
registry study [4].
In our study, there were 15 deaths, of which 8 (15%) chil-
dren died on dialysis, with sepsis and cardiovascular disease
being the main causes of death. In the ERA/EDTA registry
report, 13 of 157 (8.3%) children died while on dialysis, and
mortality was comparable in children with NPHS1 compared
to those with dysplasia [4]. The Italian registry reports similar
survival rates irrespective of the PRD: mortality rates were
10% at 1 year, 13.1% at 2 years, and 16.1% at 5 years with
infections being the main cause of death, followed by cardio-
vascular disease [16].
Our study has some limitations which are mainly within the
nature of a retrospective, descriptive analysis. Also, given that
the study is multi-center, management is likely heterogeneous
which can impact outcomes including the assessment of renal
survival time, and since CNS is a rare disease with only a few
patients per center, we are unable to correct for cofounders
such as comorbidities, regional variations in practice, or nutri-
tional status. With a high percentage of Caucasians in our
study (90%), we are unable to comment on outcomes in other
ethnic groups. However, in view of the rarity of CNS, no
prospective studies exist, and this is the largest multi-center
study providing extensive details on dialysis management,
complications, and outcomes of dialysis in children with
CNS. This report may help clinicians in their discussions with
parents about the decision-making process regarding dialysis
treatment and the short- and long-term prognosis of CNS
children.
In summary, we report that by 2 years of age, 50% of
surviving children with CNS require chronic dialysis.
Importantly, in children with CNS, the overall complication
rate, in particular the peritonitis rate and the need for changing
dialysis modalities, as well as growth and transplantation rates
are comparable to that reported in infants with other PRDs.
Although PD remains the modality of choice, HD is an ac-
ceptable alternative with comparable outcomes in children
with CNS.
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